BOLALIK DAVRIDA YUZAGA KELADIGAN AUTIZM KASALLIGINING ERTA ANIQLASH, TASHXISLASH VA DAVOLASHNING ZAMONAVIY KO‘RINISHLARI
Keywords:
farmakologik rezistentlik, depressiya, psixotik buzilish, farmakogenetika, antipsixotik, antidepressant, komorbidlik.Abstract
Ushbu maqolada depressiya va psixotik buzilishlarni davolash jarayonida uchraydigan farmakologik rezistentlik (davolashga chidamlilik) holatlari tahlil qilinadi. Farmakodinamik va farmakokinetik omillar, genetik predispozitsiya, komorbid holatlar va individual javob farqlari sababli yuzaga keluvchi terapevtik samaradorlikning pastligi asosiy muammo sifatida ko‘rsatib o‘tilgan. Shuningdek, maqolada zamonaviy yondashuvlar – polimorfizmga asoslangan farmakogenetika, transkranial magnit stimulyatsiya, psixoterapevtik qo‘shma terapiyalar va yangi preparat sinflar orqali yechimlar taklif etiladi.
References
1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). Washington, DC, 2013.
2. World Health Organization. International Classification of Diseases 11th Revision (ICD-11), 2019.
3. Lord C, Elsabbagh M, Baird G, Veenstra-Vanderweele J. Autism spectrum disorder. The Lancet. 2018;392(10146):508–520.
4. Zwaigenbaum L, et al. Early detection for autism spectrum disorder in young children. Pediatrics. 2015;136(Suppl 1):S10–S40.
5. Dawson G, et al. Randomized, controlled trial of an intervention for toddlers with autism. Pediatrics. 2010;125(1):e17–e23.
